2026. 08.19 (수) ~ 2026. 08.21 (금)
창원컨벤션센터(CECO)
| 제목 | LC-MS/MS quantification of endogenous N-lactoyl-phenylalanine and N-lactoyl-tyrosine in human plasma using a surrogate matrix approach: application to metformin-induced metabolic changes |
|---|---|
| 작성자 | 곽보영 (Seoul National University) |
| 발표구분 | 포스터발표 |
| 발표분야 | 4. Medical / Pharmaceutical Science |
| 발표자 |
곽보영 (서울대학교) |
| 주저자 | 곽보영 (서울대학교) |
| 교신저자 | |
| 저자 |
곽보영 (서울대학교) |
|
Boyoung Kwak1*, Ga-yeong Lee1 and Joo-Youn Cho1
1Department of Clinical Pharmacology and
Therapeutics, Seoul National University College of Medicine and Hospital, Seoul
03080, Korea. Email: by0324@snu.ac.kr
N-lactoyl-phenylalanine (Lac-Phe) and N-lactoyl-tyrosine
(Lac-Tyr) are endogenous metabolites associated with metabolic stress and
energy metabolism. However, their accurate quantification is challenging due to
endogenous baseline levels. This study aimed to develop and validate an
LC-MS/MS method using a surrogate matrix approach and evaluate its
applicability in human plasma following metformin administration. The method was validated according to
established bioanalytical guidelines, including assessments of accuracy,
precision, carry-over, stability, and reinjection reproducibility. Accuracy was
within 80-120% at the LLOQ and 85-115% at all other QC levels. Intra- and
inter-day precision (CV) was ≤20% at the LLOQ and ≤15% at other QC levels.
Minimal carry-over was observed (4.21% for Lac-Phe, 9.76% for Lac-Tyr), well
below the limits of 20% for analytes and 5% for the internal standard. Analyte
stability was confirmed under various storage/handling conditions. Reinjection
reproducibility met the ±15% criteria. Application of the validated method to clinical plasma samples demonstrated a significant increase in Lac-Phe and Lac-Tyr concentrations following metformin administration compared with baseline levels. These findings suggest that Lac-Phe and Lac-Tyr may serve as potential pharmacodynamic biomarkers reflecting drug-induced metabolic responses. |
|